NANO-BIOTECHNOLOGY AS FRONTIER IN TRACKING ANTIMICROBIAL RESISTANCE: MECHANISMS AND APPLICATIONS

Abstract

Antimicrobial resistance (AMR) pretenses a critical universal wellbeing hazard, demanding advanced strategies to battle drug-resistant pathogens. Nano-biotechnology, a cross-disciplinary field at the juncture of nanotechnology and biomedicine, has arisen as an auspicious opportunity for addressing this task. This abstract offers a brief impression of the role of nano-biotechnology in the battle against AMR. Nano-biotechnology controls nanomaterials and nanostructures to project new approaches for overpowering resistance mechanisms. By augmenting the effectiveness of current antimicrobial agents, nanomaterials offer a probable solution to the confines of conservative treatments. Moreover, nanocarriers empower targeted and controlled drug delivery, refining therapeutic results while minimalizing adverse effects. In addition to enhancing treatment strategies, nano-biotechnology eases the improvement of innovative diagnostics and monitoring tools. Nano-based biosensors and imaging practices enable prompt and delicate detection of drug-resistant strains, allowing for quick intervention and particular management of infections. While the potential profits are substantial, trials such as biocompatibility, noxiousness, and ethical contemplations must be addressed for accountable and safe enactment. Interdisciplinary association among investigators, healthcare professionals, and policymakers is critical to translating these progressions into practical solutions. This abstract highlight the noteworthy promise of nano-biotechnology in the constant battle against AMR, accentuating its potential to transfigure the field of infectious disease management and contribute to worldwide public health efforts.